***COVID-19 Update***: Our Venture and Innovation Award scheme remains open to applications. We would like to encourage applications relating to COVID-19 and cystic fibrosis. If you have queries about changes to grants at this time, please see our full COVID-19 Statement for researchers.
What is a Venture and Innovation Award (VIA)?
Venture and Innovation Awards allow short-term projects to take advantage of innovative opportunities and are designed to leverage additional funding. For every pound spent by the Cystic Fibrosis Trust to fund a VIA, an additional four pounds has been leveraged from an external agency.
External agencies that may also fund projects we have awarded a VIA to include industry bodies, research councils, the National Institute for Health Research and biomedical research charities
We recently funded VIAs in the areas of tackling the underlying cause of CF, understanding and treating the symptoms of CF and lung infection.
Applying for a VIA
The VIA programme is structured as a competitive leverage funding programme, where funds are only awarded following the success of an application to an external funding body. External funding bodies include government funding bodies, academic institutions and other medical research charities where applications undergo peer review.
We agree VIA funding in principle prior to submission of external funding body applications. Please contact us well in advance of your submission in order for us to consider your application, so we can add a letter of support.
The VIA programme relies on the science being peer reviewed by the external funding body, thus we can only consider applications where this peer review will take place. For industry awards, we request evidence of internal review prior to awarding funding – please contact us for the process.
If you wish to apply for a VIA, please contact us: email@example.com.